secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001420720-22-000006
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio COO Randy Maddux resigns effective May 2, 2022; stays as consultant at $10k/month
--------------------------------------------------------------------------------

- COO Randy Maddux resigned effective May 2, 2022; no disagreement with the company.
- Mike Jenkins, VP of Operations, will lead transition of COO responsibilities.
- Maddux entered a 12-month consulting agreement for $10,000/month as strategic advisor.
- Consulting agreement may be terminated by either party without cause after initial 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000006/0001420720-22-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000006/ibio-20220428x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-22-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer